Browse Items (108 total)

https://aihp.org/wp-content/uploads/2022/01/msdac-021a-dartal.jpg
Advertisement for Dartal (thiopropazate dihydrochloride), a medication manufactured by G.D. Searle & Co. to reduce anxiety. The ad appeared in the journal GP on July 1, 1959. The ad reports on the efficacy of treating a range of emotional…

https://aihp.org/wp-content/uploads/2022/01/msdac-050a-meprospan.jpg
Advertisement for Meprospan (meprobamate), manufactured by Wallace Laboratories. The ad appeared in the journal Medical Economics on January 13, 1964. The ad reports that the sustained release capsule relieves anxiety, apprehension, and tension…

https://aihp.org/wp-content/uploads/2022/01/msdac-023.1a-deprol.jpg
Advertisement for Deprol (meprobamate and benactyzine hydrochloride), a medication manufactured by Wallace Pharmaceuticals to reduce anxiety. The ad appeared in the journal Medical Economics on January 4, 1971. The ad recommends Deprol for the relief…

https://aihp.org/wp-content/uploads/2022/01/msdac-041a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on February 11, 1963. The ad reports that Librium relieves anxiety and allows…

https://aihp.org/wp-content/uploads/2022/01/msdac-045a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Times on January 1, 1963. The ad reports that Librium relieves anxiety and allows patients to…

https://aihp.org/wp-content/uploads/2022/01/msdac-044a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Times on February 1, 1963. The ad reports that Librium relieves anxiety and allows patients to…

https://aihp.org/wp-content/uploads/2022/01/msdac-099.1a-vistaril.jpg
Advertisement for Vistaril, (hydroxyzine pamoate), manufactured by Pfizer Laboratories. The ad appeared in the journal Archives of Internal Medicine on September 1, 1960. The ad recommends Vistaril for anxiety associated with cardiac disorders.

https://aihp.org/wp-content/uploads/2022/01/msdac-029.1a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on January 8, 1973. The ad recommends Librium for patients experiencing anxiety…

https://aihp.org/wp-content/uploads/2022/01/msdac-040a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on March 12, 1962. The ad reports that Librium relieves anxiety associated with…

https://aihp.org/wp-content/uploads/2022/01/msdac-006a-atarax.jpg
Advertisement for Atarax (hydroxyzine HCI), a medication manufactured by Roerig to reduce anxiety. The ad appeared in the journal Medical Economics on January 4, 1965. The ad recommends Atarax for the relief of anxiety in patients anxious about…

https://aihp.org/wp-content/uploads/2022/01/msdac-011a-atarax.jpg
Advertisement for Atarax (hydroxyzine HCI), a medication manufactured by Roerig to reduce anxiety. The ad appeared in the journal Medical Economics on January 11, 1965. The ad recommends Atarax for the relief of anxiety in patients anxious about…

https://aihp.org/wp-content/uploads/2022/01/msdac-008a-atarax.jpg
Advertisement for Atarax (hydroxyzine HCI), a medication manufactured by Roerig to reduce anxiety. The ad appeared in the journal Medical Economics on January 9, 1967. The ad recommends Atarax for the relief of anxiety in elderly patients who…

https://aihp.org/wp-content/uploads/2022/01/msdac-010a-atarax.jpg
Advertisement for Atarax (hydroxyzine HCI), a medication manufactured by Roerig to reduce anxiety. The ad appeared in the journal Medical Economics on January 10, 1966. The ad recommends Atarax for the relief of anxiety in elderly patients who…

https://aihp.org/wp-content/uploads/2022/01/msdac-014.1a-ativan.jpg
Advertisement for Ativan (lorazepam), a medication manufactured by Wyeth Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on January 1, 1979. The ad reports on the reasons that more doctors are prescribing this…

https://aihp.org/wp-content/uploads/2022/01/msdac-020.1a-centrax.jpg
Advertisement for Centrax (prazepam), a medication manufactured by Parke, Davis & Company to reduce anxiety. The ad appeared in the journal Medical Economics on January 5, 1981. The ad reports that Centrax offers low side effects as an anti-anxiety…

https://aihp.org/wp-content/uploads/2022/01/msdac-081.1a-valium.jpg
Advertisement for Valium, (diazepam), manufactured by Roche Laboratories. The ad appeared in the journal Medical Economics on January 1, 1966. The ad reports that Valium provides relief from anxiety that can cause medical complaints, such as…

https://aihp.org/wp-content/uploads/2022/01/msdac-103.1a-vistaril.jpg
Advertisement for Vistaril, (hydroxyzine pamoate), manufactured by Pfizer Laboratories. The ad appeared in the journal Medical Economics on January 6, 1969. The ad recommends Vistaril for anxiety associated with aging.

https://aihp.org/wp-content/uploads/2022/01/msdac-055.1a-miltown.jpg
Advertisement for Miltown (meprobamate), manufactured by Wallace Pharmaceuticals. The ad appeared in the journal Medical Economics on January 9, 1967. The ad reports that Miltown successfully relieves anxiety in patients across a broad range of…

https://aihp.org/wp-content/uploads/2022/01/msdac-038a-librium.jpg
Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on February 12, 1962. The ad compares the uniqueness of Librium to the uniqueness of…

https://aihp.org/wp-content/uploads/2022/01/msdac-051a-meprospan.jpg
Advertisement for Meprospan (meprobamate), manufactured by Wallace Laboratories. The ad appeared in the journal Medical Economics on January 11, 1965. The ad reports that the sustained release capsule relieves anxiety and tension.
Output Formats

atom, dc-rdf, dcmes-xml, json, omeka-xml, rss2